# Zhejiang Cellpro Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhejiang-cellpro-biotech-co

- Industry: Healthcare Specialists
- Headquarters: Ningbo, China
- Website: www.cellpro.cn
- Total disclosed funding: $5.4M
- Latest round: Series B (Jun 26, 2015)
- Investors on record: 4

## About

Established in 2012 and based in Ningbo, China, Zhejiang Cellpro Biotech Co., Ltd. is a healthcare company that focuses on the research and development of assisted reproductive technology diagnosis and treatment products.

The company engages in the research and development of assisted reproductive technology diagnosis and treatment products. Its main products include nuclear inspection, fine particle inspection and top inspection, etc. Sperm examination is a kit used for clinical diagnosis to detect sperm mitochondrial function based on flow cytometry.

## Funding rounds

- Series B, Jun 26, 2015, $2.1M — Infinity Group, China Venture Capital, Ningbo Science and Technology Financial Service Center, Dongyuan Venture Capital
- Series A, Jun 18, 2014, $3.3M — Infinity Group

## Investors

- Infinity Group (https://capitalatlas.ai/funds/infinity-group) — Series A, Series B
- China Venture Capital (https://capitalatlas.ai/funds/china-venture-capital) — Series B
- Ningbo Science and Technology Financial Service Center — Series B
- Dongyuan Venture Capital (https://capitalatlas.ai/funds/dongyuan-venture-capital) — Series B